Sri Karthikeya Bio & Pharma Projects Profile
Key Indicators
- Authorised Capital ₹ 1.20 Cr
- Paid Up Capital ₹ 5.50 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.53 Cr
- Satisfied Charges ₹ 8.00 M
- Revenue Growth 0.46%
- Profit Growth 51.35%
- Ebitda 237.35%
- Net Worth -116.39%
- Total Assets 14.45%
About Sri Karthikeya Bio & Pharma Projects
Sri Karthikeya Bio & Pharma Projects Private Limited (SKBPPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 May 2015 (Nine years and eight months 19 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 Cr and a paid-up capital of Rs 5.50 M.
The company currently has active open charges totaling ₹14.53 Cr. The company has closed loans amounting to ₹8.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sivaram Golla and Veerla Rao serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U33111TG2015PTC098912
- Company No.
098912
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 May 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sri Karthikeya Bio & Pharma Projects?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivaram Golla  | Director | 06-Aug-2015 | Current |
| Veerla Rao | Director | 13-Sep-2017 | Current |
Financial Performance of Sri Karthikeya Bio & Pharma Projects.
Sri Karthikeya Bio & Pharma Projects Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.46% increase. The company also saw a substantial improvement in profitability, with a 51.35% increase in profit. The company's net worth observed a substantial decline by a decrease of 116.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Karthikeya Bio & Pharma Projects?
Unlock access to Sri Karthikeya Bio & Pharma Projects's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sri Monashi Life Sciences Private LimitedSivaram Golla and Veerla Rao are mutual person
Panaxin Pharmaceuticals Private LimitedVeerla Rao is a mutual person
Charges (Loans)
₹14.53 Cr
₹0.80 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 14.53 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Oct 2020 | Hdfc Bank Limited | ₹2.11 M | Open |
| 13 Feb 2019 | Hdfc Bank Limited | ₹14.31 Cr | Open |
| 20 Sep 2016 | Others | ₹8.00 M | Satisfied |
How Many Employees Work at Sri Karthikeya Bio & Pharma Projects?
Sri Karthikeya Bio & Pharma Projects has a workforce of 23 employees as of Oct 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Karthikeya Bio & Pharma Projects, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Karthikeya Bio & Pharma Projects's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
